OPTImizing Malaria And HIV Treatment in a Shifting Landscape in Africa

Recruiting now · Phase 4

Conditions studied: Malaria, Hiv

In brief

A longitudinal study with four parallel cohorts with each participant followed for 2 years: two cohorts in Busia (high malaria transmission site) and two cohorts in Kampala (low malaria transmission). Each site will have a cohort of children living with HIV (CLHIV) and HIV- uninfected children and will be age-matched, enrolled in parallel, and followed for two years. All children will be enrolled without malaria infection, as determined by a negative blood smear at baseline.

Key facts

Study ID
NCT06967519
Run by
Yale University
People needed
380
Starts
2025-12-18
Expected to finish
2027-12-01
Last updated by the study team
2026-02-04

Who can join

Age: 5 and older, up to 17. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.